Prior studies in our laboratory have demonstrated that cigarette smoke condensate (CSC) activates arylhydrocarbon receptor (Ahr) leading to upregulation of several antioxidant enzymes in murine spermatocytes. In this study, we show that exposure of the spermatocyte cell line GC-2spd(ts) to CSC induces an increase in Cyp1a1, demonstrating AHR activation, and simultaneous expression and nuclear translocation of nuclear factor erythroid 2-related factor 2 (NRF2), where it is believed to modulate Ahr expression by a feedback mechanism. Pharmacological inhibition by the AHR-antagonist CH223191 and interference by Ahr-and Nrf2-small interfering RNA followed by quantitative real-time PCR implicate the Ahr-Nrf2 pathway in the modulation of DNA damage and growth suppression genes such as Gadd45a and P21 and oxidative stress-related genes Cyp1a1, Nrf2, and Ahrr. Flow cytometry accompanied with cell proliferation assay indicate the CSC induces accumulation of spermatocytes at the S-G2/M phase of the cell cycle. Thus, the data obtained suggest that CSC contains several AHR-agonists that are capable of altering the growth pattern of spermatocytes in vitro through the Ahr-Nrf2 signaling mechanism.
INTRODUCTION
Cigarette smoke contains over 4000 chemicals, 60 of which are potent carcinogens [1] . Cigarette smoking adversely affects morphology, viability, motility, and fertility of human spermatozoa as a result of the absorption and accumulation of its toxic constituents into the systemic circulation and seminal plasma of the male reproductive tract [2] . Similarly, chronic exposures to cigarette smoke arrests rodent spermatogenesis [3] , and cigarette smoke constituents act as potent testicular toxins of meiotic spermatocytes [4] . Among various factors, cigarette smoke-induced oxidative stress remains one of the major causes of male infertility [5, 6] . Although several epidemiological studies have addressed cigarette smokemediated male infertility, the molecular mechanisms mediating the oxidative damage to spermatogenesis remain ambiguous.
Cigarette smoke condensate (CSC), or tar, contains dioxins and halogenated and nonhalogenated polycyclic aromatic hydrocarbons (PAHs). These include benzo [a] pyrene and lipophilic prooxidants such as semiquinones [7, 8] . Constituents of CSC induce oxidative stress that leads to changes in gene expression in various cell and tissue types [9, 10] . For example, exposure of oral cancer cells to CSC led to upregulation of genes involved in the metabolism of PAHs [11] . The most potent dioxin, 2,3,7,8-tetrachlorodibenzo-pdioxin (TCDD), and the PAHs primarily exert their growthmodulating effects through the ligand-inducible transcription factor, aryl hydrocarbon receptor (AHR) [12, 13] . The AHR agonists in CSC and its metabolites convert AHR into a transactivator, which in turn modulates target gene expression through dioxin response elements (DREs) [14] . Similarly, reactive oxygen species (ROS) and electrophile stress activate the master regulator of oxidative stress, nuclear factor-erythroid 2-related factor 2 (Nrf2), which transcriptionally regulates genes that have antioxidant response elements (AREs) in their promoters [15, 16] . Recently, Yeager et al. [17] demonstrated that Nrf2 is required for induction of multiple Ahr target genes in the liver in response to TCDD, indicating that the Ahr and Nrf2 pathways are convergent.
A large body of evidence implicates Ahr in cell cycle control, though the precise mechanism remains obscure. This was first recognized in studies that showed that TCDD-induced thymic atrophy occurred via functional Ahr [18, 19] . Moreover, Ma and Whitlock [20] showed that Ahr-defective Hepa-1 cells exhibit growth arrest at the G1 phase, indicating that Ahr functions in cell cycle progression. Mouse embryonic fibroblasts from Ahrnull mice also show delayed S-phase progression [21] and grow slowly due to accumulation at the G2/M phase [22] . Abdelrahim et al. [23] showed that small interfering RNA (siRNA)-mediated silencing of Ahr in MCF-7 cells was accompanied by increased G0/G1 to S phase progression, whereas Ahr suppression in HepG2 cells resulted in decreased G0/G1 to S phase progression. Accordingly, ligand-activated AHR can act through interaction with phospho-renitoblastoma protein to function as a transcriptional repressor of S-phase gene expression [24, 25] . A comprehensive model that explains the apparently contradictory roles of Ahr in cell cycle control particularly in germ cells has yet to be proposed.
We previously demonstrated that CSC causes accumulation of ROS and acts through Ahr to induce expression of several antioxidant enzymes in spermatocytes, both in vitro and in vivo [26] . Furthermore, our in vivo data demonstrated that CSC induced cell death and genotoxicity in the testis. The objective of this study was to determine the cell and molecular mechanisms by which these effects on GC-2spd (ts) occurred. We provide evidence that CSC-exposed GC-2spd (ts) sper-matocytes arrest at the G2/M stage and have misregulated expression of cell growth regulators such as cyclin D1 (Ccnd1), the cell cycle inhibitor P21, and a DNA damage response gene, Gadd45a. Furthermore, we demonstrate using the GC-2spd (ts) cell line as a model that the effects on spermatocytes in vitro occur through an Ahr-Nrf2 pathway.
MATERIALS AND METHODS

Cell Culture and In Vitro CSC and Ahr-Antagonist Treatment
Cigarette smoke condensate (referred to herein as CSC) purchased from Murty Pharmaceuticals Inc. was dissolved in 100% dimethyl sulfoxide (DMSO) to obtain a 40 mg/ml stock. It was prepared using a smoking machine, and the particulate matter from Kentucky standard cigarettes (R4F) was collected on Cambridge glass fiber filters; the amount obtained was determined by weight increase of the filter. The mouse spermatocyte cell line GC-2spd (ts) (ATCC) [27] , hereafter referred to as spermatocytes, was cultured and treated with a previously optimized concentration of CSC at 100 lg/ml [26] and 10 lM AHR-specific antagonist CH223191 (2-methyl-2H-pyrazole-3-carboxylic acid-[2-methyl-4-o-tolyl-azophenyl]-amide; EMD Chemicals) [28, 29] .
Cell Counting Kit-8 Cell Proliferation Assay
Approximately 1 3 10 4 cells were plated per well in a 96-well plate and treated with CSC (100 lg/ml) as one time exposure and incubated for 24, 48, and 72 h in duplicate; an equal volume of 0.1% DMSO was used as the control. After CSC treatment, the medium in each well was replaced with 100 ll of fresh medium containing 10 ll of Cell Counting Kit-8 reagent (Dojindo Molecular Technologies). After incubation at 378C for 4 h, the amount of formazan produced by proliferating cells was measured in terms of the absorbance at 450 nm, which was measured with a microplate reader (Versamax; Molecular Devices).
Cell Cycle Analysis by Flow Cytometry
Spermatocytes (1 3 10 6 /ml) were trypsinized, washed twice in PBS containing 0.1% bovine serum albumin, fixed in 3 ml of ice-cold 70% ethanol, and stored at 48C overnight. After washing in PBS, the cells were stained with 50 lg/ml propidium iodide (Life Technologies) and 1 mg/ml RNase A (Life Technologies) for 1 h in a 378C incubator, and their DNA content was measured by using a FACScalibur flow cytometer (Becton-Dickinson). FlowJo software was used to analyze the percentages of cells in G0/G1, S, and G2/M phases.
RNA Isolation, cDNA Synthesis, and Quantitative RealTime PCR
The semiconfluent spermatocytes were serum starved for 24 h, then exposed separately to DMSO (0.1%), CSC (100 lg/ml for 2 or 6 h), CSC þ CH223191 (10 lM for 1 h), or the CH223191 alone in presence of 10% fetal bovine serum (FBS). Other cells were treated with 10 lM kynurenic acid (KYA), an endogenous AHR agonist [30] , instead of CSC. At the end of the incubation, total RNA was isolated from the treated cells and used for cDNA synthesis and quantitative real-time PCR (q-RTPCR) as previously reported [31] . Relative quantification of gene expression was performed by using TaqMan gene expression assays (Applied Biosystems) and q-RTPCR with the ABI 7500 FAST (Applied Biosystems) according to MIQE guidelines [32] with b-actin serving as the housekeeping gene because of its stability in the spermatocytes as reported earlier [26] . The 2 ÀDDCT method [33] was used to analyze gene expression data, which reflects the relative fold difference in expression of each gene between the control, treated, or siRNA-silenced groups.
Preparation of Total Cell Lysates and Nuclear Extracts
Spermatocytes grown to 70% confluence were serum starved for 24 h before being treated with CSC (100 lg/ml) for 1, 2, or 3 h. The cells were harvested, and the NE-PER kit (Pierce Biochemical Co.) was used to separate cytoplasmic and nuclear proteins. For the cyclin D1 time course study, the cells grown in Dulbecco modified Eagle medium (DMEM; Sigma-Aldrich) with growth factors were treated with CSC for 1, 2, 4, 6, and 8 h.
Chromatin Immunoprecipitation Assay
The protocol for the chromatin immunoprecipitation (ChIP) assay was slightly modified from a kit from Millipore. In brief, the spermatocytes were exposed to CSC (100 lg/ml) or DMSO (0.1%) for 1 and 2 h, then cross-linked with formaldehyde for 10 min at 378C. The harvested cells were sonicated for 11 cycles of 15-sec pulse and 10-sec pause at 60% amplitude to yield chromatin fragments of ;500 bp. Ten percent of the diluted chromatin solution was reserved as the total input sample. Aliquots of the remaining diluted chromatin solution were incubated with either an anti-Ahr antibody (2 lg/1 ml of solution) or preimmune immunoglobulin G (IgG; 2 lg/1 ml of solution). After preclearing with protein AþG agarose, immunoprecipitation was performed overnight at 48C with rotation. After washing and elution, enriched DNA was purified by phenol-chloroform extraction and ethanol precipitation and then resuspended in 21 ll of TE buffer (Quality Biological, Inc.), pH 8.0. Equal volume (2 ll) (uniform concentration) of DNA template was used for q-RTPCR analysis with customized TaqMan probe mix (Applied Biosystems). A nonrelated promoter area from b-actin was used as a negative control.
Immunolocalization of NRF2 and CYP1A1
Spermatocytes cultured with 10% FBS on a four-chambered slide (Nalge Nunc), were serum starved for 24 h and then treated with CSC (100 lg/ml) for 2 h; control cells were exposed to an equal volume of 0.1% DMSO. At the end of the incubation, the cells were fixed in 4% paraformaldehyde for 5 min, blocked in 2% bovine serum albumin and 10% normal serum, and incubated overnight with rabbit anti-NRF2 (1:50 dilution), washed with PBS, incubated with Alexa Fluor 488-conjugated goat anti-rabbit (1:500; Life Technologies) secondary antibody for 1 h, and counterstained with TO-PRO or SYTOX nuclear dye (1:500; Life Technologies) for 5 min. CSC-treated spermatocytes were also stained with rabbit anti-NRF2 and goat anti-CYP1A1 antibodies (1: 50; Santa Cruz Biotechnology). Fluorescence was observed by confocal microscopy (Nikon Eclipse E800). Negative control without primary antibody was used to confirm the specificity of staining. Signal intensity was measured by using Image J as described below.
Image Analysis
Image J software (NIH) was used for image analysis, which was performed as previously described [26] . A minimum of 15 replicate fields was analyzed for each biological specimen.
Small Interfering RNA Transfection and CSC Treatment
Spermatocytes were cultured in six-well plate or 10-mm plates in DMEM with 10% FBS and without antibiotics for 4-6 h. When the cells reached approximately 60% confluence, siRNA duplexes were transfected by using Lipofectamine RNAiMAX reagent (Life Technologies) in accordance to manufacturer's instructions. On the basis of a previous study [23] , 20 mM stock solutions of siRNAs to Ahr and Nrf2 genes and scrambled siRNAs (Ambion) were transfected alone in each well to a final concentration of 140 nM in DMEM without growth factors and antibiotics. After overnight incubation in DMEM with 10% FBS, cells were serum starved before being exposed to CSC for different treatment regimens. The transfected spermatocytes were treated with CSC for 6 h for RNA isolation. For Western blot analysis, the cells were CSC treated for 20 h (for NRF2). Each transfection assay was repeated a minimum of three times, and the results are shown as the mean 6 SEM of independent experiments.
Western Blot Analysis
After CSC treatment, cells were gently washed with ice-cold PBS and scraped into RIPA buffer (Thermo Scientific) containing 0.1 M phenylmethylsulfonylfluoride (Sigma-Aldrich), 1 mM ethylenediaminetetraacetic acid, 1 mM sodium orthovanadate, 1 mM sodium fluoride, and 13 miniprotease inhibitor cocktail (Roche Applied Science). Aliquots of 40 lg of protein from transfected and CSC-treated cells were separated by SDS-PAGE and electroblotted onto nitrocellulose membrane. The blots were probed with rabbit anti-NRF2 antibody (1:1000; Santa Cruz Biotechnology). SuperSignal West Femto Maximum Sensitivity Chemiluminescence Substrate (Pierce) was used for detection, and the blots were normalized to b-actin (1:2500; Millipore).
Statistical Analyses
The data are from three independent experiments, each assayed in duplicates or triplicates and represented as mean 6 SEM. The q-RTPCR data ESAKKY ET AL.
were analyzed by using either two-tailed unpaired t-tests or one-way ANOVA (nonparametric) followed by the Tukey multiple comparison test with 95% confidence intervals. Prism 5.0d (GraphPad) was used, and P , 0.05 was considered statistically significant.
RESULTS
CSC Inhibits Spermatocyte Proliferation In Vitro
In our earlier work [26] , we found that in vitro CSC treatment resulted in oxidative stress in spermatocytes as marked by ROS accumulation and activation of antioxidant genes. In vivo, CSC treatment resulted in histologically observable losses of germ cells and spermatocyte cell death. To begin to understand the effects of CSC on spermatocyte growth, we first examined its effects on proliferation of a spermatocyte cell line, GC-2spd (ts). By using a sensitive cell counting assay, we found that whereas DMSO-treated spermatocytes proliferated continuously over 72 h, those treated with CSC did not increase in number at all over this time (Fig. 1A) .
We next used flow cytometry to investigate the cell cycle stage at which CSC might cause growth arrest of spermatocytes. As shown in Figure 1 , B.1 and B.2, CSC treatment for 24 h caused a significant increase (;15%) in the percentage of cells at S-phase. This accumulation at S-phase was still evident at 48 h, and there was a marginal increase in the percentage of cells at the G2/M stage (P , 0.07) (Fig. 1 , C.1 and C.2). By 72 h, significantly more (;20%) of the CSC-treated cells than control cells were in G2/M, and a correspondingly lower percentage of cells were in G0/G1 (Fig. 1, D.1 and D. 2). These results suggest that CSC blocks spermatocyte cell cycle progression, especially in the S-G2/M phase.
CSC Inhibits Cyclin D1 Expression
Given that CSC-treated spermatocytes exhibited growth arrest, we hypothesized that expression of the G1 cyclin, cyclin D1 (Ccnd1), might be downregulated. As seen in Figure 2A , q-RTPCR analysis demonstrated that CSC-treated spermatocytes expressed Ccnd1 at a significantly lower level than DMSOtreated cells. We previously demonstrated that many of the CSC-induced changes in spermatocyte gene expression were dependent on Ahr [26] , so we asked whether blocking AHR with the specific antagonist, CH223191, would block this reduction of Ccnd1 gene expression. However, the transcript level remained low after pretreatment with AHR-antagonist alone or in CSC-exposed cells. In agreement with the decrease in transcript level, time-course analysis of cyclin D1 protein expression by Western blot indicated that the protein level starts decreasing after 2 h of CSC treatment (Fig. 2, B and C) .
Sequence analysis of the Ccnd1 promoter (GenBank: AF182716.1) revealed the presence of a consensus DRE (5 0 -TNGCGTG-3 0 ) [34] between À262 to À266 bp in the 5 0 UTR. To evaluate whether this DRE assists in direct recruitment of AHR to regulate cyclin D1 expression, we performed ChIP assays on spermatocytes that were treated with CSC (100 lg/ ml) for 2 h. We observed that the sequences specific to the consensus DRE in the Ccnd1 promoter could be recovered from AHR immunoprecipitates but not from preimmune IgG precipitates. Moreover, significantly higher levels of the Ccnd1 promoter DRE were recovered from AHR immunoprecipitates exposed to CSC for 2 h than from DMSO-treated controls (Fig.  2D ). These data suggest that AHR directly regulates expression of Ccnd1 in CSC-exposed spermatocytes.
To further confirm that the CSC-mediated downregulation of Ccnd1 expression was dependent on Ahr, we transfected spermatocytes with a siRNA directed against Ahr. As shown in Figure 2E , knockdown of Ahr resulted in decreased expression of Ccnd1, and CSC treatment resulted in even further decrease in Ccnd1 expression.
CSC-Activated NRF2 Undergoes Nuclear Translocation
The work of Yeager et al. [17] demonstrated that NRF2 is required for induction of multiple AHR target genes in the liver in response to TCDD. Thus, we were prompted to ask whether NRF2 was also required for the CSC-mediated changes in gene expression that we have previously reported [26] . We had previously shown that CSC causes the AHR to translocate to the nucleus, so we first wanted to determine whether NRF2, whose expression is upregulated in response to CSC, is also activated and translocates to the nucleus upon CSC exposure. As detected by immunoblot of cytoplasmic and nuclear extracts, NRF2 expression was predominantly cytoplasmic under basal conditions but proportionally increased in the nuclear extracts as early as 1 h after CSC exposure and reached a maximum between 2 and 3 h (Fig. 3, A and B) . Confocal localization of CSC-exposed spermatocytes confirmed this translocation. First, at only 20 min after CSC exposure, both NRF2 and CYP1A1 were cytoplasmic (Fig. 3C) . By 2 h after exposure, however, NRF2 protein had translocated into the nucleus and colocalized with the SYTOX nuclear stain (Fig. 3 , D and E). This finding suggests that CSC induces NRF2 expression and nuclear translocation.
Nrf2 Expression in Spermatocytes Is Ahr Dependent
We previously demonstrated that treatment of spermatocytes with an AHR antagonist blocked the CSC-mediated upregulation of Nrf2. To confirm that CSC-induced expression of NRF2 was dependent on Ahr and to determine whether constitutive NRF2 expression was also dependent on Ahr, we transiently transfected the spermatocytes with Ahr-siRNA and analyzed the expression of NRF2, in the presence or absence of CSC, by Western blot analysis. As seen in Figure 4A , knockdown by Ahr-siRNA significantly abrogated the expression of NRF2 in the absence of CSC, but siRNA silencing could not completely suppress CSC-induced NRF2 stimulation (Fig. 4B ). Our observation that the endogenous AHR ligand KYA did not upregulate Nrf2 expression (Fig. 4, C.1 and C. 2) suggests that spermatocytes may promote Nrf2 induction only in response to AHR agonists that are capable of inducing oxidative stress.
Bidirectional Cross-Talk Between Ahr and Nrf2
Given the dependency of Nrf2 expression on Ahr, we asked whether the reverse was also true, namely, is Nrf2 required for Ahr expression? We first transfected spermatocytes with siRNA to Ahr and observed significant downregulation of both Ahr and Nrf2 transcripts by q-RTPCR (Fig. 5A) . Similarly, knockdown of Nrf2 led to a decrease in the levels of Nrf2 and Ahr transcripts (Fig. 5B) . Transfection of AhrsiRNA or Nrf2-siRNA had no off-target effects on the levels of b-actin and Gapdh genes (data not shown), confirming the specificities of the siRNAs. These data indicate that Ahr and Nrf2 genes may be cross-regulating each other in a bidirectional manner at the transcriptional level.
CSC-MEDIATED CELL CYCLE AND Ahr-Nrf2 ACTIVATION FIG. 1 . Effect of CSC on proliferation and cell cycle progression of spermatocytes. A) Spermatocytes were treated with DMSO (0.1%) or CSC (100 lg/ml) for 24, 48, and 72 h, and then 10 ll of CCK-8 reagent was added to each well and incubated at 378C for 4 h. After incubation, the absorbance at 450 nm was measured using a microplate reader. Data are expressed as the mean 6 SEM of three independent experiments, each assayed in duplicate. B-D) Spermatocytes were exposed to DMSO (0.1%) or CSC (100 lg/ml) for 24, 48 and 72 h, and the percentage of cell distribution in G0/G1, S, and G2/M stages was determined by fluorescence-activated cell sorting analysis using FlowJo software (version 7.5. 
The Ahr-Nrf2 Pathway Is Required for CSC-Mediated Changes in Gene Expression
We next sought to determine whether Ahr and Nrf2 function together to regulate CSC-induced gene expression in spermatocytes. Figure 6A demonstrates that mRNA expression of the prototypical Ahr target gene, Cyp1a1, was induced several hundred fold by CSC. Small interfering RNA-mediated knockdown of Ahr and Nrf2 abrogated the CSC-induced Cyp1a1 expression. CSC exposure induced mRNA expression of the Ahr repressor (Ahrr) by approximately 7-fold (Fig. 6B ).
FIG. 2. A-C) CSC exposure and AHR-mediated expression of cyclin D1 (Ccnd1) in vitro.
A) The changes in the mRNA level of Ccnd1 gene in the control (untreated), DMSO (0.1% for 2 h), CSC (100 lg/ml for 2 h), CSC plus AHR-antagonist, and AHR-antagonist alone (10 lM for 1 h) treated spermatocytes were determined by q-RTPCR. The q-RTPCR data were normalized against the reference gene b-actin and converted to relative fold difference (DCT). The DDCT of Ccnd1 was calculated by subtracting the DCT of the control group from the DCT of the treated groups. The histogram of the Ccnd1 q-PCR data reflects the relative fold difference in its expression among the control and treated groups. Data are expressed as the mean 6 SEM of four independent experiments, each assayed in duplicate. B) Time course analysis of cyclin D1 expression by Western blot analysis. The spermatocytes were treated with DMSO (0.1% for 8 h) or CSC (100 lg/ml) for the indicated times. The harvested cells were lysed for protein extraction and subjected to SDS-PAGE and Western blot analysis using anti-cyclin D1 antibody. The blots were reprobed with anti-b-actin for normalization. C) Histogram represents cyclin D1 level in relative densitometric units normalized to b-actin (n ¼ 3). N.A., nonapplicable. D) Kinetics of AHR recruitment at the Ccnd1 promoter. Spermatocytes treated with CSC at different times were subjected to ChIP assays as described in Materials and Methods. The enriched DNA fragments pulled down using the anti-AHR antibody were analyzed by q-PCR using TaqMan primers probe that amplifies the enhancer, including the consensus DRE (5 0 -TNGCGTG-3 0 ) in the 5 0 UTR at À262 bp of the Ccnd1 promoter. A nonrelated promoter area from mouse b-actin along with preimmune IgG immunoprecipitates served as negative control. The histogram reflects the relative fold enrichment of Ccnd1promoter containing DNA fragments under specified conditions. Data are expressed as the mean 6 SEM of four independent experiments, each assayed in duplicate. E) Quantitative real-time PCR analysis was performed to assess the expression of Ccnd1 gene in the scrambled, Ahr-siRNA transfected, and Nrf2-siRNA transfected spermatocytes with or without CSC. The data were normalized and analyzed as described, and the histogram of the q-RTPCR data reflects the relative fold difference in Ccnd1 gene expression between the control and siRNA-and CSC-treated groups. CSC-MEDIATED CELL CYCLE AND Ahr-Nrf2 ACTIVATION Knockdown of Ahr but not Nrf2 suppressed the CSC-induced Ahrr mRNA induction (P , 0.05). Expression of the CDK inhibitor P21 was elevated more than 9-fold by CSC treatment, and this effect was significantly reversed in cells transfected with Ahr-siRNA. Cells transfected with Nrf2-siRNA showed a less robust decrease in expression of P21 in response to CSC exposure (Fig. 6C) . The DNA damage response gene, Gadd45a, increased ;7-fold in CSC-treated cells, and Ahrand Nrf2-siRNA transfection markedly reduced the transcription level of Gadd45a in CSC-exposed spermatocytes (Fig.  6D) . Taken together, these data indicate that the Ahr/Nrf2 pathway functions in concert to regulate gene expression.
FIG. 3. Nuclear translocation of NRF2.
A) Cytoplasmic (C) and nuclear extracts (N) were prepared at the indicated times from DMSO-or CSC-treated cells. The blots were probed with anti-NRF2 antibody and normalized to b-actin. B) Histogram represents the relative densitometric units of the expression of NRF2 level normalized to b-actin. Solid white bar ¼ cytoplasmic extracts; solid black bar ¼ nuclear extracts. The data were analyzed using the ImageJ software (n ¼ 3). C) Cells were grown on chamber slides and exposed to CSC (100 lg/ml) for 20 min and colocalized with anti-NRF2 and anti-CYP1A1 antibodies. Merged panel represents the immunosignal for NRF2, CYP1A1, and nuclear counterstain, TO-PRO. Bar ¼ 50 lm. D) Spermatocytes were exposed to DMSO (0.1%) or CSC (100 lg/ml for 2 h). After exposure, the cells were fixed and stained with anti-NRF2 antibody (green) and counterstained with SYTOX (red) to visualize the nuclei. All the cells were imaged by confocal microscopy with identical exposure conditions. Merged panels represent both the immunosignal and the nuclear counterstain. Bar ¼ 50 lm. E) Histogram represents the Image J analyzed mean nuclear intensities of the NRF2-specific fluorescence signal in the spermatocytes.
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AHR-Mediated Expression of P21, Gadd45a, and Ahrr Genes
The AHR-dependent expression of these CSC target genes was also validated using the AHR-specific pharmacological inhibitor, CH223191. As seen in Figure 7 the transcript levels of P21 (P , 0.05), Gadd45a (;9-fold), and Ahrr (P , 0.05) were significantly elevated in CSC-treated cells. The pretreatment with CH223191 has significantly blocked the CSCinduced increase in Ahrr and P21 mRNA expression but not Gadd45a (P , 0.06). The incomplete suppression of Gadd45a indicates that it might be under the regulation of alternative pathways. Thus, the AHR-antagonist-attenuated CSC induction suggests that the induced expression of Ahrr, and P21, are dependent on Ahr.
DISCUSSION
The present study demonstrates that CSC blocks spermatocyte cell cycle progression in vitro and affects expression of cell growth regulators such as Ccnd1, the cell cycle inhibitor P21, and a DNA damage response gene, Gadd45a. Furthermore, we demonstrate that CSC mediates its effects via activation of the Ahr-Nrf2 pathway. Based on this, we have proposed a model (Fig. 8) that incorporates the data presented here and from previous studies to illustrate the complexity of the pathways that lead to oxidative stress, DNA damage, and cell cycle arrest in spermatocytes. However, the entire study has been carried out using the GC-2spd (ts) spermatocyte cell line in vitro without observing significant effects of CSC on the AHR pathway of meiotic spermatocytes in vivo, and therefore, the whole phenomenon of growth inhibitory effects of CSC should be construed as GC-2spd (ts) specific.
FIG. 4. AHR-dependent expression of NRF2 protein in CSC-treated spermatocytes.
A) Western blot analysis of NRF2 expression in CSC-treated, scrambled siRNA-, and Ahr-siRNA-transfected spermatocytes with or without CSC. The blots were normalized to b-actin. B) Histogram represents the NRF2 level in relative densitometric units normalized to b-actin (n ¼ 3). C.1-C.2) Ahr-agonist kynurenic acid (KYA) does not induce Nrf2 expression in spermatocytes. The changes in the mRNA level of Nrf2 and Cyp1a1 in the control (untreated), DMSO (0.1% for 6 h), KYA (10 mM for 6 h), KYA plus CH223191, and CH223191 alone (10 lM for 1 h) treated spermatocytes were determined by q-RTPCR. The q-RTPCR data were normalized and analyzed as described for Figure 2A . The histogram reflects the relative fold difference in Nrf2 expression among the control and treated groups. Data are expressed as the mean 6 SEM of four independent experiments, each assayed in duplicate (P , 0.05).
CSC-MEDIATED CELL CYCLE AND Ahr-Nrf2 ACTIVATION Our finding shows that CSC exposure induced spermatocyte cell cycle arrest at S-G2/M phase, and that is similar to observations in other cell types. For example, previous studies have reported that PAHs of cigarette smoke, and in particular benzo [a] pyrene, cause arrest at S-G2/M in the breast carcinoma cell line, MCF-7 [35] [36] [37] . Additionally, Ahrdeficient mouse embryonic fibroblasts arrest at G2/M stage [22] . Growth arrest at G2/M phase in this study might be unexpected given that we observed that cyclin D1 expression was reduced in CSC-exposed spermatocytes. In order to understand the relationship between the Ahr-Nrf2 pathway and the expression of cyclin D1 during cell cycle progression upon CSC exposure, we used the GC-2spd (ts) spermatocyte cell line, which has the ability to proliferate and model spermatocyte germ cells in vitro. The current published data exploring the kinetics of cyclin D1 expression during male germ cell development remain inconclusive. Cyclin D1 plays a very important role in the early stage of the cell cycle, and any suppression of the gene leads to growth arrest at G0/G1 phase [38] [39] [40] . Therefore, we hypothesize that Ahr might regulate the constitutive expression of cyclin D1 in spermatocytes in the presence of growth factors and its CSC-induced modulation may involve multiple signal transduction pathways, including Ahr. Thus, the following possible scenarios can be proposed to explain why the CSC-exposed spermatocytes arrested at G2/M instead of G0/G1. As the data suggest, cyclin D1 requires Ahr transcription factor along with growth factors for its basal expression under normal condition. When exposed to CSC, we believe that the activated-AHR protein is recruited to the cyclin D1 promoter to form an inhibitory complex that suppresses cyclin D1 expression. If that had been the case, it was expected that the cyclin D1 level should remain unaffected in Ahrknockdown and CSC-treated spermatocytes. However, the persistent reduction in cyclin D1 level suggests that CSC might also activate other signaling mechanisms that warrant further studies. Meanwhile, it has been reported in cells transformed by simian virus 40 T-which is the case for the spermatocytes used in this study-that the formation of cyclin D1 complexes with cdk4/cdk6 is disrupted and cyclin D1 levels are low in these cells [41] . Therefore, it is understood that although our data indicate a direct regulation of cyclin D1 expression by Ahr in spermatocytes, the amount of cyclin D1 might be too low to influence the restriction point at the G0/G1 transition in this spermatocyte cell line. Meanwhile, it would be worth pursuing to understand how Ahr might regulate cell proliferation via cyclin D1 in a different cell type. Moreover, the less abundant cyclin D1 may be sequestered in the spermatocyte cytoplasm as observed in postmitotic neurons [42] . Interestingly, this coincides with our unpublished observation that showed cyclin D1 colocalization with GM130, a Golgi marker, in the perinuclear cytoplasm of spermatocytes.
Our finding that NRF2 expression is upregulated in response to CSC in spermatocytes is in agreement with the fact that Nrf2 is known in other systems to be the prime cellular target of exogenously induced oxidative stress and provides a cytoprotective role against environmental toxicants, including CSC [43] [44] [45] . As previously reported in another cell type [46] , we observed that NRF2 expression is AHR dependent. We present both biochemical and immunofluorescent microscopic evidence that NRF2 translocates into the nucleus in response to CSC. Although this observation is in agreement with previous studies suggesting the nuclear translocation of phosphorylated NRF2 [47] , it is opposite to an earlier report showing that NRF2 is constitutively nuclear in HepG2 and human umbilical vein endothelial cells [48] .
We demonstrated that there exists an autoregulatory loop between Ahr and Nrf2 genes in spermatocytes as has been reviewed in other systems [49] . Earlier studies had shown that the Nrf2 promoter contains functional DREs [46] , and the Ahr promoter has several AREs [50] , providing a possible mechanism by which this cross-regulation might occur. In addition, our findings that Cyp1a1 expression was undetectable when either Ahr or Nrf2 were knocked down and that CSCinduced expression of Cyp1a1 was significantly blunted are consistent with a previous report showing that both Nrf2 and Ahr are necessary for TCDD induction of NAD(P)H:quinone oxidoreductase 1 (Nqo1) in mice [17] . We also observed that the cell cycle arresting gene P21 and growth arrest-induced and DNA damage-inducible gene Gadd45a was upregulated in response to CSC. Upregulation of P21 on exposure to various genotoxic chemicals has been reported in several in vitro and in vivo studies [51, 52] . The CSC induction of Ahr-mediated P21 might inhibit the proliferation of spermatocytes through its blocking effect on the kinase activity of cyclin E-cdk-2 complex as suggested earlier [53, 54] . Gadd45a plays a vital role in controlling the G2-M checkpoint [55] and is induced in response to oxidative stress mediated through genotoxic gents such as benzo[a]pyrene [56, 57] . Gadd45a induction may serve the purpose of sensing CSC-induced DNA damage and adducts formation; we have previously shown that CSC causes such damage in spermatocytes [26] . AHRR, important in the regulation of cell growth and differentiation, is structurally similar to AHR and AHR nuclear translocator (ARNT). As shown in this study, Ahr regulated Ahrr mRNA both constitutively and in response to CSC. This is in agreement with earlier reports demonstrating Ahr-dependent regulation of Ahrr expression and tissue distribution [58, 59] . Thus, the downregulation of genes in the Ahr-antagonist-treated spermatocytes and CSC induction of these growth-suppressing genes together with the reversing effect of Ahr-and Nrf2-siRNA on CSC-mediated growth inhibition suggest a regulatory role for the Ahr-Nrf2 pathway in CSC-mediated arrest at the S-/G2-M phase of the cell cycle.
FIG. 6. A-D)
Ahr-Nrf2 activation in CSC-induced Cyp1a1, Ahrr, P21, and Gadd45a gene regulation. Quantitative real-time PCR analysis was performed to assess the expression of Cyp1a1 (A), Ahrr (B), P21 (C), and Gadd45a (D) genes in the control, Ahr-siRNA transfected, and Nrf2-siRNA transfected spermatocytes with or without CSC. Spermatocytes were transfected with control (scrambled, scr) and gene-specific siRNA to a final concentration of 140 nM in DMEM without growth factors and antibiotics. Cells were exposed to 0.1% DMSO or 100 mg/ml CSC for 6 h. The q-RTPCR data were normalized and analyzed as described for Figure 2A . The histogram of the q-RTPCR data reflects the relative fold difference in individual gene expression between the control, and siRNA-and CSC-treated groups. N.A., nonapplicable.
CSC-MEDIATED CELL CYCLE AND Ahr-Nrf2 ACTIVATION In summary, the data demonstrate that CSC-exposed GC2spd (ts) spermatocytes are growth impaired and arrested at G2/M stage. We report that this occurs through feedback regulation of downstream target genes such as Ccnd1, Cyp1a1, Nrf2, Ahrr, P21, and Gadd45a via activation of Ahr-Nrf2 pathways. Thus, the present study clearly emphasizes the detrimental effect of cigarette smoke-induced signaling mechanisms in spermatocytes, which might be reflected by the poor quality of spermatozoa in male smokers. Considering the highly complex and cell interactive nature of mammalian spermatogenesis, the data from the current study strictly reflect the CSC-mediated mechanistic events in a spermatocyte cell line that might be physiologically different from the meiotic spermatocytes in vivo, and because of the nonexistence of parallel evidence from the in vivo system, the results from this study have been extrapolated to understand events specific to GC-2spd (ts). Therefore, ongoing studies in this laboratory are focused toward developing a mouse model to address the relevance of these CSC-mediated in vitro mechanistic effects to the testicular spermatocytes under in vivo conditions and that will aid in understanding events in human smokers.
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FIG. 7.
Ahr-mediated expression of P21, Gadd45a, and Ahrr. Quantitative real-time PCR was used to determine the mRNA expression levels of P21, Gadd45a, and Ahrr genes in the control (0.1% DMSO for 6 h), CSC (100 lg/ml for 6 h), CSC plus CH223191, and CH223191 alone (10 lM for 1 h) treated spermatocytes. The q-RTPCR data were normalized and analyzed as described for Figure 2A . Square box bar ¼ DMSO; horizontal line bar ¼ CSC; diagonal line bar ¼ CSC þ CH223191; vertical line bar ¼ CH223191.
FIG. 8. Summary of the proposed CSC-mediated Ahr-Nrf2 pathway in spermatocytes. CSC induces and activates Ahr, which in turn stimulates the synthesis of Cyp1a1 via DRE by classical mechanism. CSC metabolism by Cyp1a1 causes oxidative stress through ROS, which can cause early S-phase arrest/DNA damage via adducts formation/Nrf2 induction. Continuous production of Cyp1a1 negatively regulates Ahr expression because of substrate depletion. Activated Ahr can induce Ahrr production that can either induce Cyp1a1 synthesis or in turn negatively regulate Ahr expression. Gadd45a is produced in response to DNA damage that leads to cell accumulation at G2/M phase. Nrf2 can be induced and activated directly by the constituents of CSC via excess oxidative stress or through activated Ahr under basal and induced conditions. In turn, the activated Nrf2 can directly regulate Ahr through an ARE. Induction of growth-suppressing P21 by Ahr or directly by CSC can cause G1 stage arrest through suppression of cyclin D1-CDK4/6 interaction or inhibition of cyclin E-CDK2 complex formation needed for G2/M phase progression. Regulation of oxidative stress-responsive growth-arresting genes via the Ahr-Nrf2 pathway appears to represent a mechanistic model for CSC-mediated growth inhibition of spermatocytes in vitro. Discontinuous lines indicate published studies [53, 58] .
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